Boston Interest Income from 2010 to 2026

BSX Stock

USD 92.33 1.46 1.56%

Boston Scientific Interest Income yearly trend continues to be fairly stable with very little volatility. Interest Income is likely to outpace its year average in 2026. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals

Interest Income

First Reported

2019-03-31

Previous Quarter

90 M

Current Value

99 M

Quarterly Volatility

43 M

Covid

Interest Hikes

Check Boston Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boston Scientific's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.5 B, Interest Expense of 467.3 M or Selling General Administrative of 7.2 B, as well as many indicators such as Price To Sales Ratio of 4.7, Dividend Yield of 4.0E-4 or PTB Ratio of 5.9. Boston financial statements analysis is a perfect complement when working with Boston Scientific Valuation or Volatility modules.

Build AI portfolio with Boston Stock

Check out the analysis of Boston Scientific Correlation against competitors.

The evolution of Interest Income for Boston Scientific Corp provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Boston Scientific compares to historical norms and industry peers.

Latest Boston Scientific's Interest Income Growth Pattern

Below is the plot of the Interest Income of Boston Scientific Corp over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Boston Scientific's Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Boston Scientific's overall financial position and show how it may be relating to other accounts over time.

Interest Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Interest Income

Timeline

Boston Interest Income Regression Statistics

	Arithmetic Mean	206,051,765
	Geometric Mean	97,009,552
	Coefficient Of Variation	74.76
	Mean Deviation	137,827,543
	Median	309,000,000
	Standard Deviation	154,051,299
	Sample Variance	23731.8T
	Range	467M
	R-Value	(0.28)
	Mean Square Error	23324.8T
	R-Squared	0.08
	Significance	0.28
	Slope	(8,551,495)
	Total Sum of Squares	379708.8T

Boston Interest Income History

	2026	181.8 M
	2025	123 M
	2024	107 M
	2023	22 M
	2022	470 M
	2021	341 M
	2020	361 M

Other Fundumenentals of Boston Scientific Corp

Net Interest Income

Boston Scientific Interest Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Short Term Investments	Common Stock	Long Term Debt	Good Will	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.97	0.68	0.94	0.96	0.96	0.98	0.54	0.52	0.79	0.59	0.82	0.98	-0.71	0.95	-0.33	0.85	0.73	0.86	-0.6	0.69	0.46	0.47	0.88	0.73	0.82
Total Stockholder Equity	0.99		0.93	0.77	0.94	0.94	0.9	0.96	0.5	0.42	0.77	0.49	0.79	0.99	-0.64	0.96	-0.28	0.9	0.76	0.88	-0.52	0.65	0.44	0.49	0.91	0.75	0.85
Net Debt	0.97	0.93		0.64	0.91	0.96	0.96	0.94	0.65	0.54	0.83	0.57	0.8	0.93	-0.72	0.92	-0.39	0.79	0.73	0.81	-0.65	0.75	0.57	0.36	0.86	0.66	0.77
Retained Earnings	0.68	0.77	0.64		0.73	0.58	0.48	0.64	0.35	-0.12	0.62	-0.1	0.53	0.74	-0.27	0.73	-0.15	0.8	0.81	0.76	-0.2	0.48	0.33	0.45	0.85	0.69	0.73
Accounts Payable	0.94	0.94	0.91	0.73		0.94	0.88	0.93	0.54	0.35	0.83	0.5	0.76	0.94	-0.73	0.95	-0.42	0.87	0.74	0.89	-0.67	0.65	0.46	0.47	0.89	0.72	0.83
Net Receivables	0.96	0.94	0.96	0.58	0.94		0.95	0.93	0.65	0.54	0.76	0.63	0.73	0.96	-0.7	0.97	-0.31	0.8	0.6	0.81	-0.66	0.62	0.58	0.29	0.81	0.56	0.8
Total Liab	0.96	0.9	0.96	0.48	0.88	0.95		0.95	0.56	0.67	0.78	0.72	0.83	0.9	-0.78	0.87	-0.41	0.73	0.64	0.76	-0.68	0.72	0.46	0.42	0.79	0.65	0.71
Total Current Assets	0.98	0.96	0.94	0.64	0.93	0.93	0.95		0.49	0.49	0.81	0.61	0.84	0.94	-0.79	0.92	-0.37	0.87	0.74	0.87	-0.65	0.76	0.4	0.59	0.87	0.79	0.82
Short Term Debt	0.54	0.5	0.65	0.35	0.54	0.65	0.56	0.49		0.27	0.68	0.21	0.22	0.56	-0.31	0.59	-0.15	0.33	0.21	0.42	-0.42	0.42	0.98	-0.16	0.45	0.09	0.46
Intangible Assets	0.52	0.42	0.54	-0.12	0.35	0.54	0.67	0.49	0.27		0.32	0.89	0.65	0.43	-0.53	0.36	-0.28	0.17	0.23	0.34	-0.41	0.36	0.21	0.04	0.34	0.19	0.18
Short Term Investments	0.79	0.77	0.83	0.62	0.83	0.76	0.78	0.81	0.68	0.32		0.39	0.71	0.74	-0.71	0.72	-0.6	0.69	0.71	0.74	-0.68	0.81	0.59	0.51	0.79	0.74	0.62
Common Stock	0.59	0.49	0.57	-0.1	0.5	0.63	0.72	0.61	0.21	0.89	0.39		0.69	0.5	-0.73	0.46	-0.45	0.33	0.28	0.47	-0.64	0.48	0.1	0.22	0.39	0.32	0.31
Long Term Debt	0.82	0.79	0.8	0.53	0.76	0.73	0.83	0.84	0.22	0.65	0.71	0.69		0.73	-0.8	0.69	-0.52	0.71	0.87	0.83	-0.6	0.78	0.11	0.59	0.86	0.82	0.61
Good Will	0.98	0.99	0.93	0.74	0.94	0.96	0.9	0.94	0.56	0.43	0.74	0.5	0.73		-0.6	0.98	-0.22	0.87	0.69	0.86	-0.52	0.6	0.51	0.39	0.88	0.65	0.86
Treasury Stock	-0.71	-0.64	-0.72	-0.27	-0.73	-0.7	-0.78	-0.79	-0.31	-0.53	-0.71	-0.73	-0.8	-0.6		-0.61	0.55	-0.62	-0.6	-0.68	0.85	-0.73	-0.16	-0.56	-0.66	-0.7	-0.46
Property Plant Equipment	0.95	0.96	0.92	0.73	0.95	0.97	0.87	0.92	0.59	0.36	0.72	0.46	0.69	0.98	-0.61		-0.21	0.89	0.66	0.86	-0.56	0.58	0.54	0.32	0.87	0.61	0.87
Current Deferred Revenue	-0.33	-0.28	-0.39	-0.15	-0.42	-0.31	-0.41	-0.37	-0.15	-0.28	-0.6	-0.45	-0.52	-0.22	0.55	-0.21		-0.25	-0.45	-0.34	0.69	-0.6	-0.06	-0.41	-0.36	-0.48	-0.16
Net Tangible Assets	0.85	0.9	0.79	0.8	0.87	0.8	0.73	0.87	0.33	0.17	0.69	0.33	0.71	0.87	-0.62	0.89	-0.25		0.77	0.88	-0.5	0.66	0.27	0.5	0.88	0.79	0.83
Long Term Debt Total	0.73	0.76	0.73	0.81	0.74	0.6	0.64	0.74	0.21	0.23	0.71	0.28	0.87	0.69	-0.6	0.66	-0.45	0.77		0.86	-0.44	0.76	0.12	0.63	0.92	0.86	0.69
Capital Surpluse	0.86	0.88	0.81	0.76	0.89	0.81	0.76	0.87	0.42	0.34	0.74	0.47	0.83	0.86	-0.68	0.86	-0.34	0.88	0.86		-0.57	0.71	0.34	0.52	0.96	0.76	0.9
Deferred Long Term Liab	-0.6	-0.52	-0.65	-0.2	-0.67	-0.66	-0.68	-0.65	-0.42	-0.41	-0.68	-0.64	-0.6	-0.52	0.85	-0.56	0.69	-0.5	-0.44	-0.57		-0.65	-0.31	-0.33	-0.52	-0.48	-0.42
Long Term Investments	0.69	0.65	0.75	0.48	0.65	0.62	0.72	0.76	0.42	0.36	0.81	0.48	0.78	0.6	-0.73	0.58	-0.6	0.66	0.76	0.71	-0.65		0.3	0.58	0.72	0.76	0.57
Short Long Term Debt	0.46	0.44	0.57	0.33	0.46	0.58	0.46	0.4	0.98	0.21	0.59	0.1	0.11	0.51	-0.16	0.54	-0.06	0.27	0.12	0.34	-0.31	0.3		-0.25	0.38	-0.01	0.42
Cash And Equivalents	0.47	0.49	0.36	0.45	0.47	0.29	0.42	0.59	-0.16	0.04	0.51	0.22	0.59	0.39	-0.56	0.32	-0.41	0.5	0.63	0.52	-0.33	0.58	-0.25		0.52	0.88	0.41
Net Invested Capital	0.88	0.91	0.86	0.85	0.89	0.81	0.79	0.87	0.45	0.34	0.79	0.39	0.86	0.88	-0.66	0.87	-0.36	0.88	0.92	0.96	-0.52	0.72	0.38	0.52		0.81	0.83
Net Working Capital	0.73	0.75	0.66	0.69	0.72	0.56	0.65	0.79	0.09	0.19	0.74	0.32	0.82	0.65	-0.7	0.61	-0.48	0.79	0.86	0.76	-0.48	0.76	-0.01	0.88	0.81		0.6
Capital Stock	0.82	0.85	0.77	0.73	0.83	0.8	0.71	0.82	0.46	0.18	0.62	0.31	0.61	0.86	-0.46	0.87	-0.16	0.83	0.69	0.9	-0.42	0.57	0.42	0.41	0.83	0.6

Click cells to compare fundamentals

About Boston Scientific Financial Statements

Boston Scientific investors use historical fundamental indicators, such as Boston Scientific's Interest Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Boston Scientific. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Interest Income	123 M	181.8 M
Net Interest Income	-178.2 M	-187.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

VTI	Vanguard Total Stock
RIOT	Riot Blockchain
TSLA	Tesla Inc

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Boston Interest Income from 2010 to 2026

Latest Boston Scientific's Interest Income Growth Pattern

Boston Interest Income Regression Statistics

Boston Interest Income History

Other Fundumenentals of Boston Scientific Corp

Boston Scientific Interest Income component correlations

About Boston Scientific Financial Statements

Also Currently Popular

Additional Tools for Boston Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY